Rausch, J. L., Boichuk, S., Ali, A. A., Patil, S. S., Lee, D. M., Brown, M. F., . . . Duensing, A. (2016). Opposing roles of KIT and ABL1 in the therapeutic response of gastrointestinal stromal tumor (GIST) cells to imatinib mesylate. Oncotarget.
Citación estilo ChicagoRausch, Jessica L., et al. "Opposing Roles of KIT and ABL1 in the Therapeutic Response of Gastrointestinal Stromal Tumor (GIST) Cells to Imatinib Mesylate." Oncotarget 2016.
Cita MLARausch, Jessica L., et al. "Opposing Roles of KIT and ABL1 in the Therapeutic Response of Gastrointestinal Stromal Tumor (GIST) Cells to Imatinib Mesylate." Oncotarget 2016.
Precaución: Estas citas no son 100% exactas.